Overview

Short Course: October 21
Conference: October 27-29

Digital technology is transforming the drug development process. The rise of wearable and mobile technologies along with cloud technology, Artificial Intelligence and related platforms, now enable the collection of frequent, specific, and multidimensional data throughout the length of trials. These technologies have the potential to enable innovative trial designs, improve the patient experience, act as recruitment and retention tools, and establish novel end points in clinical studies.

With these technologies, large amounts of data are collected. How to best address evaluating fit-for-purpose, standardization, ethical concerns, and regulatory approaches, are key issues to address in the digital era.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for implementing digital technology to improve clinical trials. While the conference will focus on the impact of digitalization in clinical trials today, we will make time to explore future applications and how they may enable the clinical trials of tomorrow.

Co-Sponsored with Critical Path Institute’s ePRO Consortium

Featured

Want to learn more about Digital Technology in Clinical Trials? You've come to the right site!

Who should attend?

Executive, Leadership, and Management Professionals from Biotechnology, Pharmaceutical, Device, CRO, Regulatory Agency, and Academic Research Sponsors involved in:

Business Development
Clinical Trial Design and Development
Study Endpoint Development
Clinical Research, Operations, Site Selection, and Management
Research and Development
Clinical Monitoring and Oversight
Quality Management
Contracts Management
Clinical Data Management
Data and Biostatistical Sciences
Health Economics and Outcomes Research
eClinical Technology and Solutions
Digital Strategies and Technologies
Data Analytics, Strategy, and Technology
Information Technology, Systems, and Programming
Regulatory Affairs
Patient Engagement, Recruitment, and Retention
Patient Advocacy, Partnerships, and Services
Legal and Compliance
Ethics, IRBs
Medical Affairs and Communications

Learning objectives

At the end of this conference participants should be able to:

Identify operational challenges arising due to emergence and integration of technology in clinical trials
Describe related policy, legal, and regulatory concerns
Discuss current digital technology solutions that meet the needs of patients, site staff, and organizations in the conduct of clinical trials
Identify gaps where digital technology solutions could be developed to improve patient, clinician, and organizational experience, value, and outcomes
Examine use cases or case studies addressing challenges

Short Course or Primer

To keep you at the forefront.

Oct 21, 2021

Short Course 1:

Approaches for Developing Novel Digital Endpoints for Medical Product Development

Learn more

Oct 21, 2021

Short Course 1:

Approaches for Developing Novel Digital Endpoints for Medical Product Development

Learn more

Program Committee

Sonya Eremenco, MA Executive Director, PRO Consortium
Critical Path Institute, United States
Jennifer Goldsack, MA, MBA, MS Chief Executive Officer
Digital Medicine Society (DiMe), United States
Erin Iturriaga, MSN Clinical Trials Specialist
National Heart, Lung, and Blood Institute (NHLBI), United States
Jonathan Andrus, MS Past Chair/Current Treasurer
Society For Clinical Data Management, United States
Lindsay Stiles Kehoe, MS Senior Project Manager
Clinical Trials Transformation Initiative (CTTI), United States
Bill Byrom, PhD Vice President, Product Intelligence and Positioning; Principal, eCOA Science
Signant Health , United Kingdom
Megan Doyle, JD, MPH Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly & Company, United States
Estelle Haenel, DrSc, PharmD Medical Director
Kayentis, France
Jules Mitchel, PhD, MBA President and CEO
THI Pharma Services, United States
Paul O'Donohoe, MS, MSc Senior Director, eCOA Product and Science
Medidata Solutions, United States
Lauren Oliva, PharmD, RPh US Lead, Global Regulatory Policy
Biogen, United States
Keith Wenzel Volunteer
DIA Study Endpoints Community, United States
Anindita Saha Associate Director Strategic Initiatives, Digital Health Center of Excellence
FDA, United States
Prem Sreenivasan, PhD Director
HITLAB, United States